A Clinical Study of SHR-1701 Combined With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Clinical trial NCT07607210 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07607210
Sponsor: Hebei Medical University Fourth Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Start date: 2026-06-01
Primary completion: 2026-06-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.